Development of a Low-cost NGS Test for the Evaluation of Thyroid Nodules

Vishwanath, Divya; Shanmugam, Ashwini; Sundaresh, Mahima; Hariharan, Arun K; Saraf, Shradha; Bahadur, Urvashi; Veeramachaneni, Vamsi; Chandrasekhar, Naveen Hedne; Pillai, Vijay; Bushan, Vidhya; Shetty, Vivek; Subramaniam, Narayana; Kuriakose, Moni Abraham; Shivaprasad, K S; Khadilkar, Kranti; Suresh, Amritha; Sum, Sum; Lakhsmikantha, Akhila; Rekha, Pobbisetty Radhakrishnagupta; Zaidi, Shaesta Naseem; Gupta, Vaijayanti; Kannan, Subramanian

doi:10.1007/s13193-019-01000-w

Cited by 3 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies are limited to M/F panels, and only a few genes have been studied. Most of the Indian studies on malignant thyroid nodules have looked at BRAF mutation,[ 36 ] RAS,[ 25 53 54 ] TERT,[ 25 ] RET/PTC[ 25 53 54 55 56 ] and PAX8-PPARG[ 25 ] alterations. These MT have been widely used in the evaluation of malignant nodules.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Role of Genetic Testing in the Management of Indeterminate Thyroid Nodules in the Indian Setting

Riju,

Thomas,

Paul

et al. 2024

Indian Journal of Endocrinology and Metabolism

View full text Add to dashboard Cite

The increased detection of thyroid nodules in the human population has led to an increase in the number of thyroid surgeries without an improvement in survival outcomes. Though the choice for surgery is straightforward in malignant thyroid nodules, the decision is far more complex in those nodules that get categorized into indeterminate thyroid nodules (ITN) by fine needle aspiration. Therefore, there is a pressing need to develop a tool that will aid in decision-making among the ITN. In this context, the development of various molecular testing (MT) panels has helped to confirm or rule out malignancy, reducing unnecessary surgeries and potentially guiding the extent of surgery as well. Currently, such tests are widely used among the Western population but these MT panels are not used by the South Asian population because of non-availability of validated panels and the high cost involved. There is a need to develop a suitable panel which is population-specific and validate the same. In this review, we would focus on current trends in the management of ITN among the South Asian population and how to develop a novel MT panel which is cost-effective, with high diagnostic accuracy obviating the need for expensive panels that already exist.

show abstract

Section: Introductionmentioning

confidence: 99%

“…MT are performed mostly on tissue samples and few in FNAC and plasma. MT on ITN are few[ 25 52 54 ] despite a high prevalence of thyroid nodule, and there is a clear lacuna.…”

Section: Introductionmentioning

confidence: 99%